+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antidiabetics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 90 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6090512
Description Jump to:
Antidiabetics, including insulin, SGLT-2 inhibitors, DPP-4 inhibitors, and metformin, manage diabetes, affecting 422 million people in 2022, projected to reach 522 million by 2030. The market is driven by the rising global diabetes burden, with patients facing a 2-4 times higher cardiovascular mortality risk. Advanced therapies like SGLT-2 inhibitors reduce heart failure risk by 30%, while widespread reimbursement (80% coverage in OECD countries) and lifestyle factors like obesity boost demand. Improved diagnosis and health education further propel growth. The global antidiabetics market is estimated at USD 60-90 billion in 2025, with a CAGR of 3%-7% through 2030.

Regional Market Trends

  • North America: The U.S. leads with high diabetes prevalence and advanced therapies, while Canada focuses on insulin access.
  • Europe: Germany, France, and the UK drive growth with robust reimbursement and diabetes programs.
  • Asia Pacific: China and India see rising demand due to urbanization and obesity, with Japan emphasizing SGLT-2 inhibitors.
  • Rest of the World: Brazil expands public health access, while Africa addresses diabetes complications.

Application Analysis

  • Online Pharmacies: Expected growth of 3.5%-7.5%, driven by digital access. Trends focus on subscription models.
  • Hospital Pharmacies: Projected growth of 3.2%-7.2%, linked to insulin and injectables. Advances emphasize inpatient care.
  • Retail Pharmacies: Anticipated growth of 3.0%-7.0%, suited for oral therapies. Trends highlight patient education.

Key Market Players

  • Novartis: Offers DPP-4 inhibitors for glycemic control.
  • Merck: Develops SGLT-2 inhibitors for cardiovascular benefits.
  • AstraZeneca: Provides advanced antidiabetics like GLP-1 agonists.
  • Eli Lilly: Specializes in insulin and injectables.
  • Sanofi: Focuses on affordable insulin formulations.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Low, due to high R&D costs and regulatory barriers.
  • Threat of Substitutes: Moderate, with lifestyle changes competing, but drugs are essential for severe cases.
  • Bargaining Power of Buyers: High, as generics increase price competition.
  • Bargaining Power of Suppliers: Low, with multiple API providers.
  • Competitive Rivalry: High, with players competing on efficacy and cost.

Market Opportunities and Challenges

Opportunities:

  • Addressing diabetes, affecting 422 million people globally.
  • Leveraging SGLT-2 inhibitors, reducing heart failure risk by 30%.
  • Utilizing 80% reimbursement coverage in OECD countries.
  • Meeting demand driven by obesity and urbanization.
  • Supporting improved diagnosis rates through health education.
  • Expanding access to generics in low-income regions.

Challenges:

  • High costs of novel therapies like GLP-1 agonists.
  • Patient adherence issues with long-term treatments.
  • Regulatory delays for new drugs.
  • Competition from generics reducing prices.
  • Limited healthcare infrastructure in low-income regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Antidiabetics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Antidiabetics Market in North America (2020-2030)
8.1 Antidiabetics Market Size
8.2 Antidiabetics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Antidiabetics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Antidiabetics Market in South America (2020-2030)
9.1 Antidiabetics Market Size
9.2 Antidiabetics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Antidiabetics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Antidiabetics Market in Asia & Pacific (2020-2030)
10.1 Antidiabetics Market Size
10.2 Antidiabetics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Antidiabetics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Antidiabetics Market in Europe (2020-2030)
11.1 Antidiabetics Market Size
11.2 Antidiabetics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Antidiabetics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Antidiabetics Market in MEA (2020-2030)
12.1 Antidiabetics Market Size
12.2 Antidiabetics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Antidiabetics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Antidiabetics Market (2020-2025)
13.1 Antidiabetics Market Size
13.2 Antidiabetics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Antidiabetics Market Size by Type
Chapter 14 Global Antidiabetics Market Forecast (2025-2030)
14.1 Antidiabetics Market Size Forecast
14.2 Antidiabetics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Antidiabetics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Novartis
15.1.1 Company Profile
15.1.2 Main Business and Antidiabetics Information
15.1.3 SWOT Analysis of Novartis
15.1.4 Novartis Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.2 Merck
15.2.1 Company Profile
15.2.2 Main Business and Antidiabetics Information
15.2.3 SWOT Analysis of Merck
15.2.4 Merck Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.3 AstraZeneca
15.3.1 Company Profile
15.3.2 Main Business and Antidiabetics Information
15.3.3 SWOT Analysis of AstraZeneca
15.3.4 AstraZeneca Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.4 Boehringer Ingelheim
15.4.1 Company Profile
15.4.2 Main Business and Antidiabetics Information
15.4.3 SWOT Analysis of Boehringer Ingelheim
15.4.4 Boehringer Ingelheim Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.5 Bayer
15.5.1 Company Profile
15.5.2 Main Business and Antidiabetics Information
15.5.3 SWOT Analysis of Bayer
15.5.4 Bayer Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.6 Pfizer
15.6.1 Company Profile
15.6.2 Main Business and Antidiabetics Information
15.6.3 SWOT Analysis of Pfizer
15.6.4 Pfizer Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.7 Eli Lilly
15.7.1 Company Profile
15.7.2 Main Business and Antidiabetics Information
15.7.3 SWOT Analysis of Eli Lilly
15.7.4 Eli Lilly Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.8 Takeda Pharmaceutical
15.8.1 Company Profile
15.8.2 Main Business and Antidiabetics Information
15.8.3 SWOT Analysis of Takeda Pharmaceutical
15.8.4 Takeda Pharmaceutical Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.9 Bristol-Myers Squibb
15.9.1 Company Profile
15.9.2 Main Business and Antidiabetics Information
15.9.3 SWOT Analysis of Bristol-Myers Squibb
15.9.4 Bristol-Myers Squibb Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.10 Johnson & Johnson
15.10.1 Company Profile
15.10.2 Main Business and Antidiabetics Information
15.10.3 SWOT Analysis of Johnson & Johnson
15.10.4 Johnson & Johnson Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
15.11 Sanofi
15.11.1 Company Profile
15.11.2 Main Business and Antidiabetics Information
15.11.3 SWOT Analysis of Sanofi
15.11.4 Sanofi Antidiabetics Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Antidiabetics Report
Table Data Sources of Antidiabetics Report
Table Major Assumptions of Antidiabetics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Antidiabetics Picture
Table Antidiabetics Classification
Table Antidiabetics Applications
Table Drivers of Antidiabetics Market
Table Restraints of Antidiabetics Market
Table Opportunities of Antidiabetics Market
Table Threats of Antidiabetics Market
Table COVID-19 Impact For Antidiabetics Market
Table Raw Materials Suppliers
Table Different Production Methods of Antidiabetics
Table Cost Structure Analysis of Antidiabetics
Table Key End Users
Table Latest News of Antidiabetics Market
Table Merger and Acquisition
Table Planned/Future Project of Antidiabetics Market
Table Policy of Antidiabetics Market
Table 2020-2030 North America Antidiabetics Market Size
Figure 2020-2030 North America Antidiabetics Market Size and CAGR
Table 2020-2030 North America Antidiabetics Market Size by Application
Table 2020-2025 North America Antidiabetics Key Players Revenue
Table 2020-2025 North America Antidiabetics Key Players Market Share
Table 2020-2030 North America Antidiabetics Market Size by Type
Table 2020-2030 United States Antidiabetics Market Size
Table 2020-2030 Canada Antidiabetics Market Size
Table 2020-2030 Mexico Antidiabetics Market Size
Table 2020-2030 South America Antidiabetics Market Size
Figure 2020-2030 South America Antidiabetics Market Size and CAGR
Table 2020-2030 South America Antidiabetics Market Size by Application
Table 2020-2025 South America Antidiabetics Key Players Revenue
Table 2020-2025 South America Antidiabetics Key Players Market Share
Table 2020-2030 South America Antidiabetics Market Size by Type
Table 2020-2030 Brazil Antidiabetics Market Size
Table 2020-2030 Argentina Antidiabetics Market Size
Table 2020-2030 Chile Antidiabetics Market Size
Table 2020-2030 Peru Antidiabetics Market Size
Table 2020-2030 Asia & Pacific Antidiabetics Market Size
Figure 2020-2030 Asia & Pacific Antidiabetics Market Size and CAGR
Table 2020-2030 Asia & Pacific Antidiabetics Market Size by Application
Table 2020-2025 Asia & Pacific Antidiabetics Key Players Revenue
Table 2020-2025 Asia & Pacific Antidiabetics Key Players Market Share
Table 2020-2030 Asia & Pacific Antidiabetics Market Size by Type
Table 2020-2030 China Antidiabetics Market Size
Table 2020-2030 India Antidiabetics Market Size
Table 2020-2030 Japan Antidiabetics Market Size
Table 2020-2030 South Korea Antidiabetics Market Size
Table 2020-2030 Southeast Asia Antidiabetics Market Size
Table 2020-2030 Australia Antidiabetics Market Size
Table 2020-2030 Europe Antidiabetics Market Size
Figure 2020-2030 Europe Antidiabetics Market Size and CAGR
Table 2020-2030 Europe Antidiabetics Market Size by Application
Table 2020-2025 Europe Antidiabetics Key Players Revenue
Table 2020-2025 Europe Antidiabetics Key Players Market Share
Table 2020-2030 Europe Antidiabetics Market Size by Type
Table 2020-2030 Germany Antidiabetics Market Size
Table 2020-2030 France Antidiabetics Market Size
Table 2020-2030 United Kingdom Antidiabetics Market Size
Table 2020-2030 Italy Antidiabetics Market Size
Table 2020-2030 Spain Antidiabetics Market Size
Table 2020-2030 Belgium Antidiabetics Market Size
Table 2020-2030 Netherlands Antidiabetics Market Size
Table 2020-2030 Austria Antidiabetics Market Size
Table 2020-2030 Poland Antidiabetics Market Size
Table 2020-2030 Russia Antidiabetics Market Size
Table 2020-2030 MEA Antidiabetics Market Size
Figure 2020-2030 MEA Antidiabetics Market Size and CAGR
Table 2020-2030 MEA Antidiabetics Market Size by Application
Table 2020-2025 MEA Antidiabetics Key Players Revenue
Table 2020-2025 MEA Antidiabetics Key Players Market Share
Table 2020-2030 MEA Antidiabetics Market Size by Type
Table 2020-2030 Egypt Antidiabetics Market Size
Table 2020-2030 Israel Antidiabetics Market Size
Table 2020-2030 South Africa Antidiabetics Market Size
Table 2020-2030 Gulf Cooperation Council Countries Antidiabetics Market Size
Table 2020-2030 Turkey Antidiabetics Market Size
Table 2020-2025 Global Antidiabetics Market Size by Region
Table 2020-2025 Global Antidiabetics Market Size Share by Region
Table 2020-2025 Global Antidiabetics Market Size by Application
Table 2020-2025 Global Antidiabetics Market Share by Application
Table 2020-2025 Global Antidiabetics Key Vendors Revenue
Figure 2020-2025 Global Antidiabetics Market Size and Growth Rate
Table 2020-2025 Global Antidiabetics Key Vendors Market Share
Table 2020-2025 Global Antidiabetics Market Size by Type
Table 2020-2025 Global Antidiabetics Market Share by Type
Table 2025-2030 Global Antidiabetics Market Size by Region
Table 2025-2030 Global Antidiabetics Market Size Share by Region
Table 2025-2030 Global Antidiabetics Market Size by Application
Table 2025-2030 Global Antidiabetics Market Share by Application
Table 2025-2030 Global Antidiabetics Key Vendors Revenue
Figure 2025-2030 Global Antidiabetics Market Size and Growth Rate
Table 2025-2030 Global Antidiabetics Key Vendors Market Share
Table 2025-2030 Global Antidiabetics Market Size by Type
Table 2025-2030 Antidiabetics Global Market Share by Type

Companies Mentioned

  • Novartis
  • Merck
  • AstraZeneca
  • Boehringer Ingelheim
  • Bayer
  • Pfizer
  • Eli Lilly
  • Takeda Pharmaceutical
  • Bristol-Myers Squibb
  • Johnson & Johnson
  • Sanofi

Related Topics

Related Reports

Antidiabetic Drugs Market by Drug Class, Patient Type, Route Of Administration, Distribution Channel, Therapy Type, End User - Global Forecast to 2030 - Product Image

Antidiabetic Drugs Market by Drug Class, Patient Type, Route Of Administration, Distribution Channel, Therapy Type, End User - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Diabetes Type (Type 1, 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, with Growth Forecasts, 2025-2030 - Product Image

Antidiabetics Market Size, Share & Trends Analysis Report by Drug Class (GLP-1 Receptor Agonists, Insulin), Diabetes Type (Type 1, 2), Route of Administration (Oral, Intravenous), Distribution Channel, Region, with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Antidiabetic SGLT-2 Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antidiabetic SGLT-2 Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
Antidiabetics Market Report 2025 - Product Image

Antidiabetics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region - Product Image

Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.